ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Modification of substrate specificity of L-arginine oxidase for detection of l-citrulline

L-アルギニンオキシダーゼの基質特異性改変によるL-シトルリン検出 (機械翻訳の邦題)

Yamamoto K, Masakari Y, Araki Y, et al.
研究デザイン種別未確定
対象未確定

記録の確認項目

研究デザイン
種別未確定
対象
未確定
出版年
記録なし
出典
doi.org
抄録の表示
表示あり
出版状態
未確認
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
確認待ち
記録状態
公開

出版状態の注記

出版状態: 未確認

Europe PMC lookup failed; publication status remains unknown.

状態の根拠を見る →

日本語要約(機械生成)

シトルリンは各種疾患のバイオマーカーとして有望であるが、その酵素的検出法は未確立である。本研究では、Pseudomonas sp. TPU 7192由来のL-アルギニンオキシダーゼ(ArgOX)に変異を導入し、L-シトルリン特異的酵素の開発を試みた。野生型ArgOXのオキシダーゼ活性におけるシトルリン/アルギニン比(Cit/Arg)は1.2%であったが、デヒドロゲナーゼ活性では49.5%に向上した。構造情報に基づきE486残基に変異を導入したところ、ArgOX/E486QのL-シトルリンに対するデヒドロゲナーゼ比活性は3.25 U/mgで、野生型の3.8倍となり、Cit/Arg比は150%に達した。ArgOX/E486Qを用いた検出系では、10〜500 µMのL-シトルリンで直線関係が得られ、ヒト血液中のシトルリン検出への適用可能性が示された。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Abstract
Enzymatic detection of citrulline, a potential biomarker for various diseases, is beneficial. However, determining citrulline levels requires expensive instrumental analyses and complicated colorimetric assays. Although L-amino acid oxidase/dehydrogenase is widely used to detect l-amino acids, an l-citrulline-specific oxidase/dehydrogenase has not been reported. Therefore, in this study, we aimed to develop an l-citrulline-specific enzyme by introducing a mutation into l-arginine oxidase (ArgOX) derived from Pseudomonas sp. TPU 7192 to provide a simple enzymatic l-citrulline detection system. The ratio of the oxidase activity against l-arginine to that against l-citrulline (Cit/Arg) was 1.2%, indicating that ArgOX could recognize l-citrulline as a substrate. In the dehydrogenase assay, the specific dehydrogenase activity towards l-arginine was considerably lower than the specific oxidase activity. However, the specific dehydrogenase activity towards l-citrulline was only slightly lower than the oxidase activity, resulting in improved substrate specificity with a Cit/Arg ratio of 49.5%. To enhance the substrate specificity of ArgOX, we performed site-directed mutagenesis using structure-based engineering. The 3D model structure indicated that E486 interacted with the l-arginine side chain. By introducing the E486 mutation, the specific dehydrogenase activity of ArgOX/E486Q for l-citrulline was 3.25 ± 0.50 U/mg, which was 3.8-fold higher than that of ArgOX. The Cit/Arg ratio of ArgOX/E486Q was 150%, which was higher than that of ArgOX. Using ArgOX/E486Q, linear relationships were observed within the range of 10–500 µM l-citrulline, demonstrating its suitability for detecting citrulline in human blood. Consequently, ArgOX/E486Q can be adapted as an enzymatic sensor in the dehydrogenase system.

DOI 10.21203/rs.3.rs-3013764/v1

原文・出典を見る →